Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
10,25 mg RPC1063----[1] 96 💬
20.25 mg RPC1063----[3] 13, 96, 97 💬
30.25mg RPC1063----[2] 13, 97 💬
40.5 mg RPC1063----[2] 13, 97 💬
50.5mg RPC1063----[1] 13 💬
61 mg RPC1063----[2] 13, 97 💬
71.0 mg RPC1063----[1] 97 💬
81.0mg RPC1063----[1] 13 💬
914C]-RPC1063 Solution (0.1 mg/mL) for Oral Administration----[3] 13, 96, 97 💬
101mg RPC1063----[1] 96 💬
11RPC1063----[3] 13, 96, 97 💬
12RPC1063 (equivalent to ozanimod[1] Ozanimod[1] Ozanimod 💬 [5] S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬 		[3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[1] 96 💬
13RPC1063 (equivalent to ozanimod HCl)[1] Ozanimod[1] Ozanimod 💬 [5] S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬 		[3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[1] 96 💬
14RPC1063 equiv to ozanimod HCI[1] Ozanimod[1] Ozanimod 💬 [5] S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬 		[3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[1] 96 💬
15RPC1063 equiv. to ozanimod HCI[1] Ozanimod[1] Ozanimod 💬 [5] S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬 		[3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[1] 96 💬